CD274 and head and neck squamous cell carcinoma: In head and neck squamous cell carcinoma (HNSCC), the overexpression of let-7a/b miRNAs in combination with CTLA-4 antibody promotes anticancer immunity by accelerating PD-L1 degradation [129].